NCT01050374已完成不适用
Gaps in Helminth Control: Safety and Efficacy of Drug Combinations. Praziquantel Study
DBL -Institute for Health Research and Development1 个研究点 分布在 1 个国家目标入组 650 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 650
- 试验地点
- 1
- 主要终点
- Efficacy of treatment
研究概览
简要总结
This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of MBD in combination with PZQ in the treatment of SCH and STH in children aged 1-15 years of age.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 1 Year 至 15 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Those with an age of 1-15 years of age
- •Are infected with schistosomiasis and soil-transmitted helminthiasis
- •Whose parent consent and who are willing to participate
排除标准
- •Those with acute and chronic diseases other than schistosomiasis and soil-transmitted helminthiasis
- •Those with a history of any serious adverse drug reactions
研究组 & 干预措施
1
Placebo Comparator
albendazole + praziquantel
干预措施: albendazole + praziquantel (Drug)
2
Active Comparator
mebendazole + praziquantel
干预措施: mebendazole + praziquantel (Drug)
结局指标
主要结局
Efficacy of treatment
时间窗: 6 weeks
次要结局
- Record of adverse reactions(6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Safety and Efficacy of Drug Combinations Against Trichuris TrichiuraParasitic DiseasesNCT01050452DBL -Institute for Health Research and Development750
已完成
不适用
Safety and Efficacy of Drug Combinations Against Triple InfectionsParasitic DiseasesNCT01050517DBL -Institute for Health Research and Development250
已完成
不适用
A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head LiceHead LiceNCT01803581Oystershell NV60
已完成
3 期
Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in NamibiaMalariaNCT02610400University of California, San Francisco9,845
已完成
2 期
Cholinergic Urticaria - Efficacy of DupilumabCholinergic UrticariaNCT03749148Charite University, Berlin, Germany48